PD01-01: Safety and efficacy of enzalutamide by ereatment duration in the Asian subgroup from ARCHES: A post hoc analysis

PD01-02: Knockdown of EPS8 expression may attenuate disease progression in enzalutamide-resistant prostate cancer

PD01-03: Neoadjuvant therapy in initially inoperable upper tract urothelial carcinoma – a comparative study with adjuvant strategies

PD01-04: Study on the pro-tumor function of UBE2C gene in metastatic prostate cancer and tts potential as a therapeutic marker

PD01-05: ChatGPT-4 as a tool for patient education: artificial intelligence and urological cancer-related queries

PD01-06: Retroperitoneal laparoscopic adrenalectomy for large adrenal tumors—analysis of tumor size and adverse events: A retrospective single-center study